Hydrogen: A Novel Treatment Strategy in Kidney Disease

Background: Hydrogen is a chemical substance that has yet to be widely used in medicine. However, recent evidence indicates that hydrogen has multi-faceted pharmacological effects such as antioxidant, anti-inflammatory, and antiapoptotic properties. An increased number of studies are being conducted...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Wang (Author), Zhuoshu Li (Author), Longfei Mao (Author), Mingyi Zhao (Author), Bingchang Yang (Author), Xiaowu Tao (Author), Yuxiang Li (Author), Guangming Yin (Author)
Format: Book
Published: Karger Publishers, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8463f75c06b84c73b866a1bb06bb9cc1
042 |a dc 
100 1 0 |a Bo Wang  |e author 
700 1 0 |a Zhuoshu Li  |e author 
700 1 0 |a Longfei Mao  |e author 
700 1 0 |a Mingyi Zhao  |e author 
700 1 0 |a Bingchang Yang  |e author 
700 1 0 |a Xiaowu Tao  |e author 
700 1 0 |a Yuxiang Li  |e author 
700 1 0 |a Guangming Yin  |e author 
245 0 0 |a Hydrogen: A Novel Treatment Strategy in Kidney Disease 
260 |b Karger Publishers,   |c 2022-01-01T00:00:00Z. 
500 |a 2296-9381 
500 |a 2296-9357 
500 |a 10.1159/000520981 
520 |a Background: Hydrogen is a chemical substance that has yet to be widely used in medicine. However, recent evidence indicates that hydrogen has multi-faceted pharmacological effects such as antioxidant, anti-inflammatory, and antiapoptotic properties. An increased number of studies are being conducted on the application of hydrogen in various diseases, especially those affecting the renal system. Summary: Hydrogen can be inhaled, as a gas or liquid, and can be administered orally, intravenously, or locally. Hydrogen can rapidly enter suborganelles such as mitochondria and nucleus by simple diffusion, producing reactive oxygen species (ROS) and triggering DNA damage. Hydrogen can selectively scavenge hydroxyl radical (•OH) and peroxynitrite (ONOO−), but not other reactive oxygen radicals with physiological functions, such as peroxyanion (O2−) and hydrogen peroxide (H2O2). Although the regulatory effect of hydrogen on the signal transduction pathway has been confirmed, the specific mechanism of its influence on signal molecules remains unknown. Although many studies have investigated the therapeutic and preventive effects of H2 in cellular and animal experiments, clinical trials are few and still far behind. As a result, more clinical trials are required to investigate the role of hydrogen in kidney disease, as well as the effect of its dose, timing, and form on the overall efficacy. Large-scale randomized controlled clinical trials will be required before hydrogen can be used to treat renal illnesses. Key Messages: This article reviews the mechanisms of hydrogen in the treatment of renal disease and explores the possibilities of its use in clinical practice. 
546 |a EN 
690 |a hydrogen 
690 |a kidney disease 
690 |a anti-inflammatory 
690 |a antioxidant 
690 |a cell death 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Kidney Diseases, Pp 1-11 (2022) 
787 0 |n https://www.karger.com/Article/FullText/520981 
787 0 |n https://doaj.org/toc/2296-9381 
787 0 |n https://doaj.org/toc/2296-9357 
856 4 1 |u https://doaj.org/article/8463f75c06b84c73b866a1bb06bb9cc1  |z Connect to this object online.